Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-023-8 | CAS number: 50-28-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
Test system |
Substance |
Application |
End point/Effect |
Literature |
Pig |
14C-estradiol |
Infusion into selected portions of the gastro- intestinal tract of gilts. |
Blood samples were collected from the jugular and portal veins. The concentration of free estrogens in the jugular vein was low (< 1%) The concentration of conjugated estrogens in the jugular vein peaked rapidly after instillation. 60-90% of the radiolabel in blood was present as glucuronide conjugates; smaller amounts of sulfated compounds were detected and approximately 1% as diconjugates. The principal steroid identified after cleavage by ß-glucuronidase and sulfatase was estrone. Conjugation occurs as estradiol crosses the mucosa of the gastrointestinal tract, and free estradiol in the ortal plasma is conjugated during the first pass through the liver. |
Moore et al., 1982. J. Anim. Sci., 55, 124-134 as cited by Toxicological Evaluation of certain Veterinary Drug Residues in Food. WHO Food Additives Series: 43, prepared by the Fifty-second meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 2000. |
Pig |
17ß-Estradiol- D-glucuronide |
Instillation into sections of intestineof gilts. |
Blood samples were collected from the jugular and portal veins. The limiting factor in absorption of conjugates was hydrolysis to free estrogen. |
Pohland et al., 1982 J. Anim. Sci., 55, 145-152as cited by Toxicological Evaluation of certain Veterinary Drug Residues in Food. WHO Food Additives Series: 43, prepared by the Fifty-second meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 2000. |
Pig |
Gestadiol-17ß- D-glucuronide |
Gavage |
A possible dose-limiting rate of absorption was observed at the highest dose (4 mmol 3H- estradiol glucuronide) |
Coppoc et al., 1982,J. Anim. Sci., 55, 135-144 as cited by Toxicological Evaluation of certain Veterinary Drug Residues in Food. WHO Food Additives Series: 43, prepared by the Fifty-second meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 2000. |
Pig |
Crystalline estradiol (10 mg in cocoa butter) |
Gavage |
The concentrations of estradiol, estrone, estradiol glucuronide, and estrone sulfate in the hepatic portal vein rose within 5 min and remained elevated for several hours. Estrogens administered orally are conjugated by the gut wall and pass to the liver, where they enter either the bile pool for enterohepatic circulation or the bloodstream. |
Ruoff & Dziuk, 1994. Domest. Anim. Endocrinol., 11, 197-208 as cited by Toxicological Evaluation of certain Veterinary Drug Residues in Food. WHO Food Additives Series: 43, prepared by the Fifty-second meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 2000. |
Wister Rat, female |
17ß-Estradiol |
Intravenous administration of 0.1 mg/kg bw Gavage of 10 mg/kg bw |
Concentrations of estradiol in liver was 20 times higher after intragastric than after intravenous administration. Absolute bio- availability was 8.3% after an intragastric dose of 10 mg/kg bw. The total clearance was 154 ml/min per kg bw. The half-life of estradiol in liver was 2.6 h |
Schleicher et al., 1998. Pharmacol. Toxicol., 82, 34-39 as cited by Toxicological Evaluation of certain Veterinary Drug Residues in Food. WHO Food Additives Series: 43, prepared by the Fifty-second meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 2000 |
Rat, female |
Levonorgestrel and 17ß-Estradiol |
Dermal patch for a period of 7 days |
Only slight changes in serum-level over the time of application. Systemic drug exposure was 0.048 µg h/mL/d or 500 µg/d for Estradiol- |
Final Report No. KIST10000001, Schering AG, Concentration of Levonogestrel and Estradiol in rat serum following application of estradiol/Levonogestrel transdermal combination patches over a period of 7 days, dated 09 Sept. 1999. |
|
|
|
Circulating estradiol is bound to sex hormone-binding globulin (SHBG) and, to a lesser extent, serum albumin. Only 1-2% of circulating estradiol is unbound; 40% is bound to SHBG and the remainder to albumin. |
Carr, 1998. In: Wilson et al., eds, Williams Textbook of Endocrinology, 9th Ed.,, W.B. Saunders Co., pp. 751-817 as cited by Toxicological Evaluation of certain Veterinary Drug Residues in Food. WHO Food Additives Series: 43, prepared by the Fifty-second meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 2000 |
|
|
|
Estrogens are eliminated in faeces and urine. The principal metabolites found in urine are polyhydroxylated forms conjugated at C3 to glucuronic acid or sulfate. Elimination in bile is subject to enterohepatic circulation, and 20% of estrogens may be lost through faecal elimination. |
Lewis et al., 1998 Eur. J. Gastroenterol. Hepatol., 10, 33-39 as cited by Toxicological Evaluation of certain Veterinary Drug Residues in Food. WHO Food Additives Series: 43, prepared by the Fifty-second meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 2000 |
|
|
|
Two main competing, irreversible pathways for estradiol hydroxylation are 2-or 4-hydroxylation and 16 alpha- hydroxylation. |
Michnovicz et al., 1989. Metabolism, 38, 537-541. 817 as cited by Toxicological Evaluation of certain Veterinary Drug Residues in Food. WHO Food Additives Series: 43, prepared by the Fifty-second meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 2000 |
Hamster, in vitro, liver microsomes |
|
|
Does dependency of metabolism. 16alpha-hydroxylation predominates at low (< 25 µmol/L) concentrations, whereas 16 alpha-and C2-hydroxylation contributed equally to estradiol metabolism at higher concentrations. |
Butterworth et al., 1996Drug. Metab. Disposition, 24, 588-594 as cited by Toxicological Evaluation of certain Veterinary Drug Residues in Food. WHO Food Additives Series: 43, prepared by the Fifty-second meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 2000. |
Syrian hamster |
|
|
Metabolism in Kidney: 2-hydroxy formation after catalysis by CYP1A1/2 and CYP3A |
Hammond et al., 1997.Toxicol. Appl. Pharmacol., 145, 54-60 as cited by Toxicological Evaluation of certain Veterinary Drug Residues in Food. WHO Food Additives Series: 43, prepared by the Fifty-second meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 2000. |
Mouse CYP1B1 expressed in E. coli |
|
|
Significant differences in steroid metabolism are seen between rodents and humans. Human but not mouse CYP1B1, was identified as an estrogen 4- hydroxylase,. |
Savas et al., 1997. Arch. Biochem. Biophys., 347, 181-192 as cited by Toxicological Evaluation of certain Veterinary Drug Residues in Food. WHO Food Additives Series: 43, prepared by the Fifty-second meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 2000. |
Syrian hamster, in vitro, liver and kidneys lysosomes, male |
|
|
Deconjugation of estradiol and estrone glucuronides with rates of 56% and 34%, respectively.
Demethylation of catechol estrogens with fivefold higher rates in liver than in kidney. |
Zhu et al., 1996. Toxicol. Appl. Pharmacol., 136, 186-193as cited by Toxicological Evaluation of certain Veterinary Drug Residues in Food. WHO Food Additives Series: 43, prepared by the Fifty- second meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 2000. |
|
|
|
Redox cycling of catechol (hydroxyquinone) to quinone through semiquinone intermediates is catalysed by oxidation of catechol estrogens by peroxidases or CYP1A1 lipid hydroperoxide cofactors. Oxygen radicals formed in this redox process may increase the carbonyl content of proteins, formation of DNA adducts, and lipid peroxidation. It was concluded that redox cycling is a critical step in estrogen-mediated carcinogenesis. |
Yager & Liehr, 1996. Annu. Rev. Pharmacol. Toxicol., 36, 203-232 as cited by Toxicological Evaluation of certain Veterinary Drug Residues in Food. WHO Food Additives Series: 43, prepared by the Fifty-second meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 2000. |
|
|
|
In general, estradiol is inactive when given orally because it is inactivated in the gastrointestinal tract and liver, although fine-particle formulations of estradiol are effective when given orally and are used therapeutically. The bioavailability of a single 4-mg dose of fine-particle estradiol administered orally to 14 young women was 5% of that of a dose administered intravenously. At least 60% of the absorbed dose appeared in the serum as estrone and estrone sulfate and was available as part of the endogenous pool. Estradiol shows little toxicity when given as a single oral dose. Few conventional short-and long-term studies of the systemic toxicity of estradiol in animals treated orally were available, but there is sufficient information to demonstrate that the reverse effects of estradiol seen in animals are associated with estrogenic activity. Because of the specificity and affinity with which estradiol binds to its receptors, the hormonal effects occur at much lower doses than other toxicological responses and hence are the most appropriate for use in evaluating the safety of the compound. |
Toxicological Evaluation of certain Veterinary Drug Residues in Food. WHO Food Additives Series: 43, prepared by the Fifty-second meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 2000. |
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.